- IBS is a complex polygenic disorder with substantial environmental modulation affecting phenotype and risk.
- Despite numerous candidate gene and GWAS loci, the role of genetic testing for IBS in routine clinical practice remains uncertain.
- Emergent areas such as pharmacogenetics and nutrigenetics may provide more immediate clinical applications guiding medication and dietary interventions.
Gastroenterol Clin North Am. 2026 Dec;55(4):741-758. doi: 10.1016/j.gtc.2026.07.003. Epub 2026 Sep 9.
ABSTRACT
Irritable bowel syndrome (IBS) is a complex genetic disorder characterized by polygenic susceptibility with substantial environmental modulation. While many candidate gene studies and large genome-wide association studies have identified loci associated with IBS susceptibility, the role of genetic testing for IBS in clinical practice is uncertain. Instead, emergent areas such as pharmacogenetics and nutrigenetics may offer more immediate clinical applications by guiding medication or dietary interventions.
PMID:42933944 | DOI:10.1016/j.gtc.2026.07.003
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

